Jump to content

The 39th Annual Meeting of the Japanese Association for Animal Cell Technology (JAACT2026)

Shonan iPark
July 28–29, 2026

Meet Genedata experts at JAACT2026 and learn how Genedata solutions efficiently support the whole biopharmaceutical R&D workflow, including analysis and interpretation of data for cell and gene therapy development, screening and protein engineering, expression and purification, characterization and analysis of protein therapeutics, cell line design and development, bioprocess optimization, stratification of clinical trial subjects, and quality control of biologicals.

Genedata Selector® is an end-to-end solution providing a single source of truth to integrate, analyze, and share all project-related NGS data for improved decision-making. It supports efficient decision-making during R&D of vaccine, antibody, cell and gene therapy, and more.

To schedule a meeting in advance or receive more information in Japanese, please contact .

Recommended Poster Presentation

[P-48] Advancing Cell Therapies Using NGS as a Multi-Attribute Method
Ryo Masuda, Ph.D., Scientific Account Manager, Genedata
Wednesday, July 29 | 1:35 - 2:25 pm JST


Learn More